(Q41469801)

1 October 2017

1 reference

title

The renal consequences of arterial hypertension (English)

1 reference

1 October 2017

Mountokalakis TD

1

1 reference

PubMed ID

9150485

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

51

1 reference

1 October 2017

5

1 reference

1 October 2017

1639-1653

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.226

1 October 2017

0 references

cites work

Hypertensive vascular disease; description and natural history

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Progression of renal insufficiency: role of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Progressive renal disease: role of race and antihypertensive medications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal insufficiency in treated essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Association between blood pressure and the rate of decline in renal function with age

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal function during antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

The renal circulation in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Increased urinary albumin-excretion rate in benign essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Long-Term versus Short-Term Effects of Hydrochlorothiazide on Renal Haemodynamics in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Effects of Chronic Beta-Adrenergic Blockade on Systemic and Renal Haemodynamic Responses to Hyperosmotic Saline in Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Effects of prazosin therapy on BP, renal function, and body fluid composition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Are angiotensin-converting enzyme inhibitors the renal protective antihypertensive drugs of choice?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Nifedipine versus fosinopril in uninephrectomized diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Comparative effects of different antihypertensive treatments on progression of diabetic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Microalbuminuria as a predictor of clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Long-term effects of antihypertensive agents on proteinuria and renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

The kidney in hypertension--villain and victim

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Sodium-proton exchange and primary hypertension. An update

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Intracellular pH and Na+/H+ antiport activity of cultured skin fibroblasts from diabetics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Nephropathy in NIDDM is associated with cellular markers for hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Renal biopsy findings in presumed hypertensive nephrosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Initiation of hypertension in utero and its amplification throughout life.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Low birth weight and risk of high blood pressure in adulthood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Does early nutrition in infants born before term programme later blood pressure?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Controlled low protein diets in chronic renal insufficiency: meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Serum uric acid in essential hypertension: an indicator of renal vascular involvement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Usefulness of ophthalmoscopy in mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Effect of lisinopril monotherapy on renal hemodynamics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood--a 27-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.226

7 January 2021

Identifiers

DOI

10.1038/KI.1997.226

1 reference

1 October 2017

1 reference

PubMed ID

9150485